Previous close | 0.2000 |
Open | 0.2000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 65.00 |
Expiry date | 2024-06-21 |
Day's range | 0.2000 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Beyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Moderna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous trading session.